Semen Processing for ICSI Using Swim-down and Density Gradient Methods

December 30, 2014 updated by: Ahmad Mustafa Mohamed Metwalley

Novel Approach of Semen Preparation to Improve ICSI Outcome.

The investigators evaluate the feedback of using swim down semen processing method during preparation for ICSI and compare the results of pregnancy and embryos quality with the cases used density gradient method for their semen processing.

Study Overview

Detailed Description

There is different semen processing method, in this study we compared the ICSI output when the investigators used one method with higher separation method and minimum sperm stress or physical interface as swimming down using 100 % silica solution, with other more stressful procedure with high selection power as density gradient.

The routine used method as density gradient (DG) includes about 30 min centrifugation at 1200 RPM, and more working steps with more handling procedures. According to many references the investigators can approve that it is method to be indicated with all cases particularly with those severely decreases semen number or motility.

Using 100 % silica solution for semen processing used for ICSi, shews lesser centrifugation time and minimum processing procedures. As swimming down time is about 30 min followed by 5 min washing and finalized with other 3 minutes last wash. For that total interfering physical action is about 8 minutes compared with 30 min with DG method.

In swimming down we are using the natural sperm behavior and own swimming power for separate itself from other seminal components. As well as only the one normally structure and motility direction the only can penetrate the interface surface of silica solution and swim inside higher density matrix using its speed and power.

Study Type

Observational

Enrollment (Actual)

890

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Adliyah
      • Manama, Adliyah, Bahrain, 15006
        • Al Baraka Fertility Hospital
      • Sohag, Egypt, 15006
        • Ibn Sina IVF Center- Ibn Sina Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Cases collected were submitted for ART treatment using ICSI/IVF procedures. In two different IVF clinics at Manama-Bahrain and Sohag-Egypt. The groups of about 890 couple prepared for treatment.

Description

Inclusion Criteria: all semen samples fresh or frozen that has,

  • Cases have semen examination criteria fall within WHO 2010 standards of count
  • Cases have semen examination criteria fall within WHO 2010 standards of motility
  • Cases have semen examination criteria with all types of abnormal forms
  • Cases produced more than 4 mature oocytes (M2) and more

Exclusion Criteria:

  • Cases have semen examination criteria with motility less than 5%
  • Cases have semen examination criteria with count less than 1.0 million
  • Cases with TESE, TESA and EPSA, both fresh and frozen
  • Cases produced less than 4 mature oocytes (M2)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Density Gradient semen

ICSI Cases processed using DG semen processing and evaluated by

Blastocyst Formation Rate Blastocyst Rate Pregnancy Rate

Embryos developed at Day3 cultures, are continued for Day5 culture tho reach blastocyst stage. The percentage of blastocyst produced from cleaved embryos to be evaluated ar rate.

The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Other Names:
  • Blastocyst developed form cleaved embryos

Day 5 embryo transfer achieved pregnancy are compared with total embryo transfer cases at Day5.

The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.

Other Names:
  • Pregnancey produced formblastocyst embryo transfer

All pregnancy achieved from all ET. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.

The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Other Names:
  • Pregnancy achieved after all ET
Swimming down semen

ICSI Cases processed using SD semen processing and evaluated by

Blastocyst Formation Rate Blastocyst Rate Pregnancy Rate

Embryos developed at Day3 cultures, are continued for Day5 culture tho reach blastocyst stage. The percentage of blastocyst produced from cleaved embryos to be evaluated ar rate.

The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Other Names:
  • Blastocyst developed form cleaved embryos

Day 5 embryo transfer achieved pregnancy are compared with total embryo transfer cases at Day5.

The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.

Other Names:
  • Pregnancey produced formblastocyst embryo transfer

All pregnancy achieved from all ET. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.

The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Other Names:
  • Pregnancy achieved after all ET

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Pregnancy Rate
Time Frame: 3 Years
Percentage of Pregnancies developed after embryo transfer, for maternal age less than 38 years old.
3 Years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blastulation Rate (BR)
Time Frame: 3 years
Percentage of blastocyst embryos produced from cleaved embryos, for maternal age less than 38 YO.
3 years
Blastocyst formation Rate (BFR)
Time Frame: 3 Years
Developed embryos developed to Blastocyst stage from cleaved embryos.
3 Years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ahmad M Metwalley, Ms. Genetics, Adliyah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2007

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

December 28, 2014

First Submitted That Met QC Criteria

December 30, 2014

First Posted (Estimate)

December 31, 2014

Study Record Updates

Last Update Posted (Estimate)

December 31, 2014

Last Update Submitted That Met QC Criteria

December 30, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AlBarakaSD1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Blastocyst Formation Rate

3
Subscribe